Delivery Order SPE2DB25D3020-SPE2DB25FWKNW
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,102.82 to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,174.04 to AmerisourceBergen Drug Corp for supply of ADDYI (flibanserins) 100 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 9, 2025, and was awarded on May 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a $5,184.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserina) 100 mg tablets in quantities of 30 units. This delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency Troop Support Medical awarded a $1,598.85 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg Addyi tablets. The order is for 30 tablets to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 14, 2023, in support of the Agency's medical supply needs. Amerisourcebergen will serve as the prime contractor on this small order to provide pharmaceutical products to DLA Troop Support Medical, the Agency tasked...
- The Defense Logistics Agency awarded a $4,319.32 firm fixed price delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. The award was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and represents a non-set-aside, competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply ADDYI 100 MG TABLET pharmaceuticals. The $3,199.38 order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA to provide a comprehensive range of medications and medical supplies to military treatment programs and facilities worldwide....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (flibanserin) in a quantity of 30 units, valued at $5,525.08. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserene) 100 mg tablets in quantities of 30 units, with a ceiling value of $41,739.01. This firm fixed price delivery order, awarded September 4, 2025, with ultimate completion by September 5, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (flibanserin) on August 21, 2025, with a ceiling value of $7,861.63 and an ultimate completion date of August 22, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,037.90 to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units). The contract, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, employs firm fixed-price pricing and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKNWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Addyi 100 mg tablets in quantities of 30 units, valued at $4,767.92. This competitively awarded, non-set-aside contract was executed on September 11, 2025, with an ultimate completion date of September 12, 2025, and operates under firm fixed pricing terms. The pharmaceutical supply will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle extending through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. As the leading pharmaceutical distributor for federal medical procurement, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 9/11/25 |